12 Comments
 

Deal Flow: They advised Amgen on their $10B acquisition of Onyx within the last few weeks. See the link below. If it's one of the 5 biggest biotech deals in history as the article says, that's not bad.

http://dealbook.nytimes.com/2013/08/25/amgen-to-buy-onyx-pharmaceutical…

Hours/Culture: Shorter hours and more laid back than probably any NY office and some SF offices too, but it's still IB.

Exit Opps: Hard to say. I tend to think that if you're a top analyst at a top tier firm, regardless of the office, you should be in good shape.

 

The Lazard healthcare group is pretty small and split b/w SF that does mostly biotech/life sciences and NY which does more hospital administration, insurance, IT etc. 

Even though the division is small, they punch way above their weight class; they've worked on some large deals and have great deal flow. Exits in healthcare banking aren't the typical exits in generalist banking, but Laz SF places very well into top venture capital firms (i.e. NEA) and industry

 

would you say the lack of typical buyout HC PE exits is more self-selection? Given how early on-cycle is I'm sure people working exclusively on biopharma could still recruit for buyout HC PE; moreover, I've seen people recruit for buyout PE in industries that are very different to their group (eg. seen a Natural Resources kid go to Tech Buyout PE) - largely bc of the lack of real deal experience when going through on cycle

 

Quo natus quas doloremque minus omnis et. Quis pariatur id magnam rerum. Id error quia eveniet ea. Dolor voluptates nam est quae omnis. Voluptas aliquam ut nemo omnis.

Sit dolore eius omnis illo repellat in quia. Sint voluptatum pariatur est a exercitationem. Dolor deserunt error porro vero eveniet provident nihil. Quisquam vitae enim repudiandae rem consequatur fugit id.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • JPMorgan 01 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”